title: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
abstract: BACKGROUND/AIMS--The course of primary sclerosing cholangitis (PSC) is highly variable and unpredictable. This study describes the natural history and outcome of PSC. These data were used to construct a prognostic model for patients with PSC. METHODS--A total of 305 Swedish patients with PSC were studied. The median follow up time was 63 (1-194) months and all patients could be traced for follow up. Some 79 patients died or had a liver transplant. The prognostic significance of clinical, biochemical, and histological findings at the time of diagnosis were evaluated using multivariate analysis. RESULTS--The estimated median survival from time of diagnosis to death or liver transplantation was 12 years. Cholangiocarcinoma was found in 24 (8%) of the patients and 134 (44%) of the patients were asymptomatic at the time of diagnosis. The estimated survival rate was significantly higher in the asymptomatic group (p < 0.001). However, 29 (22%) of the asymptomatic patients became symptomatic during the study period. It was found that age, serum bilirubin concentration, and histological stage at the time of diagnosis were independent predictors of a bad prognosis. These variables were used to construct a prognostic model. CONCLUSIONS--This prognostic model developed from a large homogeneous population of PSC patients should be of value for the timing of transplantation and patient counselling in PSC.
authors.affiliation: Department of Medicine, Huddinge Hospital, Stockholm, Sweden.
authors.forename: U
authors.initials: U
authors.lastname: Broomé
authors.forename: R
authors.initials: R
authors.lastname: Olsson
authors.forename: L
authors.initials: L
authors.lastname: Lööf
authors.forename: G
authors.initials: G
authors.lastname: Bodemar
authors.forename: R
authors.initials: R
authors.lastname: Hultcrantz
authors.forename: A
authors.initials: A
authors.lastname: Danielsson
authors.forename: H
authors.initials: H
authors.lastname: Prytz
authors.forename: H
authors.initials: H
authors.lastname: Sandberg-Gertzén
authors.forename: S
authors.initials: S
authors.lastname: Wallerstedt
authors.forename: G
authors.initials: G
authors.lastname: Lindberg
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D002648:Child; D002675:Child, Preschool; D018281:Cholangiocarcinoma / Q000150:complications; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013548:Sweden